Search results
Abbott Labs Enters The U.S. Obesity Arena
Investor's Business Daily· 2 days agoAbbott Laboratories (ABT) gained U.S. clearance Monday for a pair of new continuous glucose monitors. The Food and Drug Administration signed off on...
New Study Finds That This Common Low-Calorie Sweetener Could Increase Your Risk of a Heart Attack or...
First for Women via Yahoo News· 6 days agoIs there a way to fight blood clots and heart attacks possibly resulting from xylitol? As of now,...
Opinion | Mexico is ground zero as China takes Global South battle to US backyard
South China Morning Post· 3 days agoHistorically, Western polices have triggered China’s engagement with what is now termed the Global...
People With Eating Disorders Are Being Prescribed Ozempic — and the Results Are Dire
PopSugar· 7 hours agoIf you've followed health and wellness news and trends over the last couple of years, you're likely...
FitSpresso Scam Or Saviour? (Latest News) Does It Really Work? What You Must Know Before Buying This...
MSN News· 6 days agoFitSpresso is a weight loss supplement that focuses on optimizing the body’s natural fat-burning...
US maternal mortality rate the highest among high-income countries
World Socialist Web Site· 5 days agoIn Norway, the maternal mortality rate in 2022 reached zero deaths per 100,000. Although the US...
More young people are having strokes. A doctor shares 3 ways to help prevent them.
Business Insider· 6 days agoKeeping stroke risk factors, such as high blood pressure and being overweight, under control can...
Here’s Billionaire George Soros’s Favorite Weight Loss Stock
Insider Monkey via Yahoo Finance· 19 hours agoWe recently published a list of 9 Best Stocks to Buy in 2024 According to Billionaire George Soros....
GROWING OLD UNGRACEFULLY: Fact or Fiction-fulness?
Lost Coast Outpost· 3 days agoWhen the late Hans Rosling and his co-authors (son and daughter-in-law) published Factfulness: Ten Reasons We’re Wrong about the World — and Why Things are Better than You ...
Eli Lilly Pushes Alzheimer's Stocks Lower On FDA Win
Investor's Business Daily· 12 hours agoDespite the stock move, analysts largely expect donanemab to gain FDA approval. Late Monday, the advisors to the FDA voted unanimously that the clinical...
